ICUI vs LLY · P/E 74, rev $2.38B vs P/E 39, rev $65.18B
ICU Medical Inc (ICUI) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
ICU Medical Inc (ICUI) is a medical instruments & supplies company listed on NASDAQ.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Latest reported ICUI revenue for 2024-12-31 was $2.38B. Net income was -$117.7M. Revenue was up 5.4% from 2023-12-31 to 2024-12-31. ICUI currently screens at market cap $3.45B and trailing P/E 73.8.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
ICUI currently screens at market cap $3.45B and trailing P/E 73.8. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the ICUI and LLY stock pages for the full models.
Not investment advice.